Pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC), ranks among the most prevalent malignancies and is a leading cause of cancer-related mortality worldwide. Therefore, there is an urgent need to identify novel anti-pancreatic cancer agents. This study reports a newly identified homogeneous polysaccharide, designated ESPPW, isolated from Arthrospira platensis (A. platensis). The molecular weight of ESPPW is estimated at 356 kDa, and it consists predominantly of glucose and rhamnose, with minor amounts of mannose, glucuronic acid, galacturonic acid, galactose, xylose, arabinose, and fucose. ESPPW inhibits the proliferation and migration of PDAC cells both in vitro and in vivo. Mechanistic investigations reveal that ESPPW induces apoptosis through activation of caspase-3 and is associated with upregulation of the tumor-suppressor protein p53. Notably, treatment with 2.8 nmol·L−1 of ESPPW leads to significant time-dependent downregulation of galectin-3 (Gal-3) and glypican-6 (GPC-6). These findings are corroborated by immunohistochemical analysis of tumor xenograft tissues. Furthermore, overexpression of Gal-3 and GPC-6 reverses the pro-apoptotic effect of ESPPW, as indicated by restored cycle regulatory proteins (CDK2) expression. In conclusion, these data demonstrate that ESPPW suppresses PDAC cell growth by promoting apoptosis and disrupting the functional activity of Gal-3 and GPC-6.
Funding
This work was supported by Shanghai Municipal Science and Technology Major Project, the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDA12020373), the New Drug Creation and Manufacturing Program (No. 2019ZX09735001), the Ministry of Science and Technology, the People Republic of China and National Natural Science Foundation of China (No. 81903762), and the Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University, No. CMEMR2016-B02).
Supporting information
Supporting information for this work can be obtained by contacting the corresponding authors via E-mail.
Declaration of competing interest
The authors declare that they have no competing interests.
| [1] |
Hidalgo M, Cascinu S, Kleeff J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology. 2015; 15(1):8-18. https://doi.org/10.1016/j.pan.2014.10.001.
|
| [2] |
Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014; 74(11):2913-2921. https://doi.org/10.1158/0008-5472.CAN-14-0155.
|
| [3] |
Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet. 2011; 378(9791):607-620. https://doi.org/10.1016/S0140-6736(10)62307-0.
|
| [4] |
Neuzillet C, Gaujoux S, Williet N, et al. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC). Dig Liver Dis. 2018; 50(12):1257-1271. https://doi.org/10.1016/j.dld.2018.08.008.
|
| [5] |
Filmus J, Selleck SB.Glypicans: proteoglycans with a surprise. J Clin Invest. 2001; 108(4):497-501. https://doi.org/10.1172/JCI200113712.
|
| [6] |
Kirn-Safran C, Farach M, Carson D. Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci. 2009; 66(21):3421-3434. https://doi.org/10.1007/s00018-009-0096-1.
|
| [7] |
Dinccelik-Aslan M, Gumus-Akay G, Elhan AH, et al. Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma. Mol Clin Oncol. 2015; 3(3):584-590. https://doi.org/10.3892/mco.2015.486.
|
| [8] |
Gao W, Kim H, Feng M, et al. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy. Hepatology. 2014; 60(2):576-587. https://doi.org/10.1002/hep.26996.
|
| [9] |
Li N, Spetz MR, Ho M. The role of glypicans in cancer progression and therapy. J Histochem Cytochem. 2020; 68(12):841-862. https://doi.org/10.1369/0022155420933709.
|
| [10] |
Li J, Kleeff J, Kayed H, et al. Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells. Biochem Biophys Res Commun. 2004; 320(4):1148-1155. https://doi.org/10.1016/j.bbrc.2004.06.063.
|
| [11] |
Matsuda K, Maruyama H, Guo F, et al. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res. 2001; 61(14):5562-5569. https://doi.org/10.1016/S0165-4608(01)00481-2.
|
| [12] |
Harada E, Serada S, Fujimoto M, et al. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma. Oncotarget. 2017; 8(15):24741-24752. https://doi.org/10.18632/oncotarget.15799.
|
| [13] |
Li N, Fu H, Hewitt SM, et al. Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma. Proc Natl Acad Sci U S A. 2017; 114(32):E6623-E6631. https://doi.org/10.1073/pnas.1706055114.
|
| [14] |
Fernandez D, Cercato M, Guereño M, et al. Glypican-3 (GPC3) signaling pathway involved in breast cancer progression. Cancer Res. 2018; 78(13):4508-4508. https://doi.org/10.1158/1538-7445.AM2018-4508.
|
| [15] |
Sakane H, Yamamoto H, Matsumoto S, et al. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling. J Cell Sci. 2012; 125(2):449-460. https://doi.org/10.1242/jcs.091876.
|
| [16] |
Li F, Shi W, Capurro M, et al. Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling. J Cell Biol. 2011; 192(4):691-704. https://doi.org/10.1083/jcb.201008087.
|
| [17] |
Ni M, Yang X, Liu L, et al. Lentivirus-carrying glypican-6 shRNA inhibits viability and colony formation of human nasopharyngeal carcinoma cells. Int J Clin Exp Med. 2018; 11(7):6731-6739.
|
| [18] |
Shi W, Kaneiwa T, Cydzik M, et al. Glypican-6 stimulates intestinal elongation by simultaneously regulating Hedgehog and non-canonical Wnt signaling. Matrix Biol. 2020; 88:19-32. https://doi.org/10.1016/j.matbio.2019.11.002.
|
| [19] |
Yiu GK, Kaunisto A, Chin YR, et al. NFAT promotes carcinoma invasive migration through glypican-6. Biochem J. 2011; 440(1):157-166. https://doi.org/10.1042/BJ20110530.
|
| [20] |
Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta. 2006; 1760(4):616-635. https://doi.org/10.1016/j.bbagen.2005.12.020.
|
| [21] |
Wehrhan F, Büttner-Herold M, Distel L, et al. Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas. BMC Cancer. 2018; 18(1):823. https://doi.org/10.1186/s12885-018-4726-6.
|
| [22] |
Kobayashi T, Shimura T, Yajima T, et al. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. Int J Cancer. 2011; 129(12):2775-2786. https://doi.org/10.1002/ijc.25946.
|
| [23] |
Yao Y, Zhou L, Liao W, et al.HH1-1, a novel galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking galectin-3/EGFR/AKT/FOXO3 signaling pathway. Carbohydr Polym. 2019; 204:111-123. https://doi.org/10.1016/j.carbpol.2018.10.008.
|
| [24] |
Zhang L, Wang P, Qin Y, et al. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Oncogene. 2017; 36(9):1297-1308. https://doi.org/10.1038/onc.2016.306.
|
| [25] |
Omstedt PT, von der Decken A, Hedenskog G, et al. Nutritive value of processed Saccharomyces cerevisiae, Scenedesmus obliquus and Spirulina platensis as measured by protein synthesis in vitro in rat skeletal muscle. J Sci Food Agric. 1973; 24(9):1103-1113. https://doi.org/10.1002/jsfa.2740240913.
|
| [26] |
Chang M, Liu K. Arthrospira platensis as future food: a review on functional ingredients, bioactivities and application in the food industry. Int J Food Sci Technol. 2024; 59(3):1197-1212. https://doi.org/10.1111/ijfs.16882.
|
| [27] |
Piñero EJE, Bermejo BP, Villar del FAM. Antioxidant activity of different fractions of Spirulina platensis protean extract. Farmaco. 2001; 56(5-7):497-500. https://doi.org/10.1016/s0014-827x(01)01084-9.
|
| [28] |
Qu X, Cui S, Xie J, et al. Antitumor studies on the polysacchrides Spirulina platensis. Chin J Mar Drugs. 2000; 19(4):10-14.
|
| [29] |
Koníčková R, Vaňková K, Vaníková J, et al. Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds. Ann Hepatol. 2014; 13(2):273-283. https://doi.org/10.1016/S1665-2681(19)30891-9.
|
| [30] |
Zhang CQ, Chen X, Ding K. Structural characterization of a galactan from Dioscorea opposita Thunb. and its bioactivity on selected Bacteroides strains from human gut microbiota. Carbohydr Polym. 2019; 218:299-306. https://doi.org/10.1016/j.carbpol.2019.04.084.
|
| [31] |
Honda S, Akao E, Suzuki S, et al. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives. Anal Biochem. 1989; 180(2):351-357. https://doi.org/10.1016/0003-2697(89)90444-2.
|
| [32] |
Feng Q, Cao HL, Xu W, et al. Apoptosis induced by genipin in human leukemia K562 cells: involvement of c-Jun N-terminal kinase in G2/M arrest Acta Pharmacol Sin. 2011; 32(4):519-527. https://doi.org/10.1038/aps.2010.158.
|
| [33] |
Kobayashi T, Shimura T, Yajima T, et al. Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells. Clin Exp Metastasis. 2011; 28(4):367-376. https://doi.org/10.1007/s10585-011-9376-x.
|
| [34] |
Wu LC, Ho JA, Shieh MC, et al. Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. J Agric Food Chem. 2005; 53(10):4207-4212. https://doi.org/10.1021/jf0479517.
|
| [35] |
Lu Y, Chen Z, Lin Q, et al. Anti-colon cancer effects of Spirulina polysaccharide and its mechanism based on 3D models. Int J Biol Macromol. 2023; 228:559-569. https://doi.org/10.1016/j.ijbiomac.2022.12.244.
|
| [36] |
Chu WL, Lim YW, Radhakrishnan AK, et al. Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals. BMC Complement Altern Med. 2010; 10:53. https://doi.org/10.1186/1472-6882-10-53.
|
| [37] |
Marková I, Koníčková R, Vaňková K, et al. Anti-angiogenic effects of the blue-green alga Arthrospira platensis on pancreatic cancer. J Cell Mol Med. 2020; 24(4):2402-2415. https://doi.org/10.1111/jcmm.14922.
|
| [38] |
Moll UM, Wolff S, Speidel D, et al. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol. 2005; 17(6):631-636. https://doi.org/10.1016/j.ceb.2005.09.007.
|
| [39] |
Nakahara S, Oka N, Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis. 2005; 10(2):267-275. https://doi.org/10.1007/s10495-005-0801-y.
|
| [40] |
Lavra L, Ulivieri A, Rinaldo C, et al. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas. J Pathol. 2009; 218(1):66-75. https://doi.org/10.1002/path.2510.
|
| [41] |
Torii K, Nishizawa K, Kawasaki A, et al. Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways. Cell Signal. 2008; 20(7):1256-1266. https://doi.org/10.1016/j.cellsig.2008.02.013.
|
| [42] |
Tang Q, Chen C, Zhang Y, et al. Wnt5a regulates the cell proliferation and adipogenesis via MAPK-independent pathway in early stage of obesity. Cell Biol Int. 2018; 42(1):63-74. https://doi.org/10.1002/cbin.10862.
|
| [43] |
Osone S, Hosoi H, Kuwahara Y, et al. Fenretinide induces sustained‐activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species‐dependent manner in neuroblastoma cells. Int J Cancer. 2004; 112(2):219-224. https://doi.org/10.1002/ijc.20412.
|
| [44] |
Zhou Y, Kipps TJ, Zhang S. Wnt5a signaling in normal and cancer stem cells. Stem Cells Int. 2017; 2017(1): 5295286. https://doi.org/10.1155/2017/5295286.
|
| [45] |
Melleby AO, Strand ME, Romaine A, et al. The heparan sulfate proteoglycan glypican-6 is upregulated in the failing heart, and regulates cardiomyocyte growth through ERK1/2 signaling. PLoS One. 2016; 11(10):e0165079. https://doi.org/10.1371/journal.pone.0165079.
|
| [46] |
Fukushi J, Makagiansar IT, Stallcup WB. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin. Mol Biol Cell. 2004; 15(8):3580-3590. https://doi.org/10.1091/mbc.e04-03-0236.
|
| [47] |
Wen Y, Makagiansar IT, Fukushi J, et al. Molecular basis of interaction between NG2 proteoglycan and galectin-3. J Cell Biochem. 2006; 98(1):115-127. https://doi.org/10.1002/jcb.20768.
|
PDF
(4971KB)
